This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $1,584.00, is a Fixed Price Delivery Order with Economic Price Adjustment for the purchase of the ACP MAX PRP SYSTEM (OUS/EU). This award is not associated with a set-aside program. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has a...
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, by the Defense Logistics Agency (DLA). The contract is for the procurement of the ACP MAX PRP SYSTEM (W/ ACDA), a specialized orthopedic product. The fixed-price contract with economic price adjustment has a ceiling value of $1,514.70 and a period of performance through September 10, 2024. Arthrex, a for-profit Subchapter S Corporation based in Naples, Florida, has received...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $1,514.70, is for the delivery of the "4566415286 ! ACP MAX PRP SYSTEM (W/ ACDA)" product. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type and an Ultimate Completion Date of November 18, 2024. This contract award is not...
This federal contract award, identified as SPE2DE24DA017|SPE2D625F34YT, was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The $1,127.94 fixed-price with economic price adjustment delivery order contract is for the procurement of the ACP MAX PRP SYSTEM (W/ ACDA), a specialized orthopedic medical product. Arthrex, a for-profit Subchapter S Corporation, has demonstrated extensive capabilities...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $3,633.30, is a Delivery Order for an "ACP MAX PRP SYSTEM (W/ ACDA)" and has a fixed price with economic price adjustment pricing type. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 9, 2025. The contract was not designated as a...
This is a delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the ACP MAX PRP SYSTEM (OUS/EU), a medical device used in orthopedic procedures, with a ceiling value of $15,759.00. The contract is a Fixed Price with Economic Price Adjustment, with a period of performance through March 6, 2025. Arthrex Inc. is a for-profit Subchapter S Corporation...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $7,573.50 fixed-price delivery order is for the 4566485933 ACP MAX PRP SYSTEM (W/ ACDA), with a period of performance ending on November 22, 2024. Arthrex, a for-profit Subchapter S Corporation, has a robust portfolio of orthopedic medical products, including surgical implants, arthroscopic...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $1,650.00 fixed-price with economic price adjustment delivery order is for the Arthrex ACP Double Syringe System, a specialized medical device used for orthopedic procedures. The contract has an ultimate completion date of December 27, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in...
This federal contract award, valued at $2,475.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of the Arthrex ACP Double Syringe System, a specialized medical device used in orthopedic procedures. The contract has an ultimate completion date of January 8, 2025 and is a Delivery Order with a Fixed Price with Economic Price...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $18,961.99, is for the delivery of Arthrex's ACP Double Syringe System, a specialized medical device used in orthopedic procedures. This is a Fixed Price with Economic Price Adjustment contract with a completion date of December 16, 2024. The contract is not designated as a set-aside....